Pharmacotherapy of COVID-19

Journal Title: Advances in Clinical Toxicology - Year 2020, Vol 5, Issue 3

Abstract

Corona virus disease is a pandemic that first reported from Wuhan City of China and later spread to other parts of the world. It is a highly contagious disease though the mortality rate is less compared to other corona virus disease seen in the last two decades. Most of the infected individuals are asymptomatic and goes unnoticed. However, 5-10 percent requires hospitalization and 1-3 percent may need critical care management. There is no proven drug for the disease, but many existing drugs are repurposed for this disease with variable degree of success. Few clinical trials are completed and some are still undergoing. An attempt is made to give an overview of various drugs available at present for the management of COVID-19 and in various stages of their development.

Authors and Affiliations

Bairy LK* and Bhat R

Keywords

Related Articles

Evaluation of Synergistic Formulation Extract of Traditional Contraceptive Plants for Acute Oral Toxicity

In folk medicine, certain plants are used to prevent pregnancy. The purpose of the study was to evaluate the synergistic formulation of conventional contraceptive herb’s acute toxicity. Acute toxicity refers to a negativ...

Strategic Assessment of Rational Drugs use in Tertiary Care Hospital Peshawar, Pakistan

Background: Rational drugs are safe, effective and medico-socio-economical for the patients. The rational use of drugs required to achieve the optimal state of the patient by community affordable cost, the “WHO” indicat...

Chronic Fumonisin Intake Induces Erythrocyte Osmotic Fragility

Fumonisin B1 (FB1) is a mycotoxin that appears as a frequent maize and maize-based foods contaminant in Argentina. It has an inhibitory effect of ceramide synthetase, a key enzyme in the biosynthesis of sphingolipids, i...

Preclinical Pharmacology and Toxicology

It is imperative to have safety and efficacy evaluation completed for a test compound before proceeding to translate for clinical trials. Preclinical pharmacology and toxicological studies play an essential role for pro...

Advanced Cognitive Emotional Regulation Therapy (ACERT) for Addiction Treatment

The last decades have shown relevant improvement in the therapeutic strategies aimed at psychiatric symptoms; however, addiction treatment remains unclear and controversial. Although there are specific medications ap...

Download PDF file
  • EP ID EP751717
  • DOI 10.23880/act-16000194
  • Views 51
  • Downloads 0

How To Cite

Bairy LK* and Bhat R (2020). Pharmacotherapy of COVID-19. Advances in Clinical Toxicology, 5(3), -. https://europub.co.uk./articles/-A-751717